CA45422-3B - 0x00000000000067A7

Healthy Males & Females

Alchemy

* Stipend may pay up to reflected amount.
Start Date: 
November 7, 2025 - 7:30am
End Date: 
February 27, 2026 - 8:10am

Study Details

Study Number: CA45422
Group Number: 3B
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,500.00

Study Criteria

Age: 19 - 65
BMI: 18 - 32
Weight Restriction: minimum weight 110 lbs

Study Information

Indication: This investigational medication is being developed to treat ALS (often called Lou Gehrig's disease) which causes muscle weakness and paralysis.
Route of Administration: Injection IV infusion
Blood Draws: 22

Study Schedule

Schedule Type: Short stays with returns
Study Length: 4- Night Stay, 6 Returns & 1 Phone Call

Screening Dates (appointments available in Lincoln and Omaha):

Event Day Event Date
Friday 10/24/2025
Friday 10/31/2025
Monday 11/3/2025

Doctor Exam Dates (appointments available in Lincoln and Omaha):

Event Day Event Date
Friday 10/24/2025
Friday 10/31/2025
Monday 11/3/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Return Friday 11/7/2025 7:30:00 AM Friday 11/7/2025 8:30:00 AM 1L Lincoln
Check-In Thursday 11/13/2025 1:40:00 PM Monday 11/17/2025 8:10:00 AM 1 Lincoln
Phone participant Friday 11/21/2025 11:10:00 AM 1 Lincoln
Return Saturday 11/29/2025 7:10:00 AM Saturday 11/29/2025 8:10:00 AM 1 Lincoln
Return Friday 12/12/2025 7:10:00 AM Friday 12/12/2025 8:10:00 AM 1 Lincoln
Return Friday 1/9/2026 7:10:00 AM Friday 1/9/2026 8:10:00 AM 1 Lincoln
Return Friday 1/30/2026 7:10:00 AM Friday 1/30/2026 8:10:00 AM 1 Lincoln
Return Friday 2/27/2026 7:10:00 AM Friday 2/27/2026 8:10:00 AM 1 Lincoln